Medical Tech Outlook Weekly Brief
Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
The Food and Drug Administration-approved device is the first and only DBS system in the U.S. with state-of-the-art BrainSense technology that allows clinicians to capture patient brain signals, enabling more data-driven, personalized treatment for patients with neurological disorders such as Parkinson's disease, severe tremor, and epilepsy.
FREMONT, CA: The Pacific Neuroscience Institute is the Providence Health System's first provider to treat a patient with an advanced, surgically implanted Deep Brain Stimulation unit. Providence is a global, non-profit Catholic health system made up of a large family of organizations and founded on the principle that health is a human right.
Used to treat symptoms of movement disorders like Parkinson's disease, the Percept PC Neurostimulator with BrainSense technology has been produced by Medtronic as a Deep Brain Stimulation (DBS) next-generation system. The Food and Drug Administration-approved device is the first and only DBS system in the U.S. with state-of-the-art BrainSense technology that allows clinicians to capture patient brain signals, enabling more data-driven, personalized treatment for patients with neurological disorders such as Parkinson's disease, severe tremor, and epilepsy.
The Pacific Neuroscience Institute (PNI) is committed to offering specialized services to people with a wide variety of neurological and cranial disabilities. A dedicated staff of professionals, state-of-the-art equipment, and the utilization of innovative care along with a collaborative strategy ensure that any patient gets the attention they deserve for the right treatment and rehabilitation.
DBS uses a small, pacemaker-like device, positioned under the chest or abdomen's skin, to deliver electronic signals to a brain area that controls movement. The new DBS device offers critical feedback to optimize treatment for patients with Parkinson's disease and other movement disorders. Benefits include improved tremor, stiffness, slow motion, and overall quality of life.
The treatment technology can be considered for people who no longer have an acceptable combination of efficacy and side effects for their existing therapies. Patients are presented with detailed and customized diagnostic and care evaluations to decide if DBS is the right alternative. This DBS system is available to new patients. Besides, for those wishing to upgrade an older Medtronic DBS system, their existing brain leads are compatible with the new Percept PC Neurostimulator that can replace their currently implanted device.
Read Also
